Citius Aims To Use Prior Experience With CTCL Drug To Its Commercial Advantage

 
• By Alaric DeArment
  
Citius announced results of its Phase III trial of I/Ontak in cutaneous T-cell lymphoma • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Rare Diseases

More from Scrip